Cancer research. Cancer prevention with a diabetes pill?
Gary
G
Taubes
D000091162:AMP-Activated Protein Kinase Kinases; D055372:AMP-Activated Protein Kinases / Q000378:metabolism; D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood / Q000378:metabolism; D008687:Metformin / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D009369:Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D013002:Somatomedins / Q000378:metabolism
D016588:Anticarcinogenic Agents; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013002:Somatomedins; D008687:Metformin; D017346:Protein Serine-Threonine Kinases; C109790:STK11 protein, human; D000091162:AMP-Activated Protein Kinase Kinases; D055372:AMP-Activated Protein Kinases